Naomi Laing

Naomi Laing is an innovative clinical leader in oncology who is driven by science. With a strong background in translational science and drug discovery, Naomi has held various leadership roles in companies such as AstraZeneca, Bristol Myers Squibb, and invoX Pharma Limited. Naomi has extensive experience in developing external collaborative strategies and delivering trials in the field of Immuno-Oncology, focusing on late-stage assets and combination therapies. With a PhD in Biochemistry from McMaster University and a BSc in Biochemistry and Nutrition from the University of Guelph, Naomi's expertise and leadership have been instrumental in advancing oncology research and drug development.